AZD0486 for RR FL
AZD0486, a CD19 x CD3 Bispecific Antibody, for Relapsed/Refractory Follicular Lymphoma

Released: December 09, 2024

Expiration: December 08, 2025

Activity

Progress
1
Course Completed